Atopic Dermatitis Systemic Therapies are topped by upadacitinib 30 mg in meta-analyses.

Published Date: 04 May 2023

Updated analysis of more than a dozen clinical trials evaluating upadacitinib as a monotherapy systemic treatment for atopic dermatitis reveals the drug's highly pervasive skin-clearing efficacy.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

When Should Immunocompromised Individuals Receive a COVID Booster?

2.

Home Screening Appeals to Women Facing Healthcare Barriers

3.

Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer

4.

Prolonged Screen Time Linked to Sleep Issues in Preschoolers

5.

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot